Latest Breaking News On - Nihar pandey - Page 1 : vimarsana.com

Medipure Holdings Inc. Announces a Filing of its Provisional Patent for Psoriasis Treatment Share Article Treatment for Inflammatory Skin Conditions Added to Innovative Pharmaceutical Company’s Portfolio of Prescription Medications This is an exciting time for Medipure given our business development and growth, and developing MP-30X has strengthened our portfolio of drugs pipeline and I am grateful for our superb team and all they have done and continue to do. VANCOUVER, British Columbia (PRWEB) May 19, 2021 Medipure Pharmaceuticals Inc. (“MPI”), a wholly owned subsidiary of Medipure Holdings Inc. (together with MPI, “Medipure” or the “Company”), a biopharmaceutical incubator committed to discovering and developing proprietary prescription drugs focused on the endocannabinoid system, is pleased to announce the submission of provisional patent application to the United States Patent and Trademar

United statesBritish columbiaBoris weissNihar pandeyTrademark officeMedipure pharmaceuticals incMedipure holdings incMedipure holdingsUnited states patentChief scientific officerPatent cooperation treatyNote regarding forward looking informationPress releaseஒன்றுபட்டது மாநிலங்களில்பிரிட்டிஷ் கொலம்பியாபோரிஸ் வெயிஸ்